UnitedHealth


At a Glance

  • Revenue down slightly; EBIDTA up $400M
  • Early price increase in quarter, followed by significant drop

Rolling 12 months financials

Year over year financials


Stock Performance

MA = moving average; GSPC = S&P 500

Analyst buy/sell recommendations

Insider sentiment for quarter- Negative

Based on trading behaviors of company officers and directors trading in their own stock


Earnings Call Summary

No call transcript available at time of writing 


Other indicators

Innovation score - Outperforming sector

Based on R&D activities. 


Deeper reading



END OF REPORT

x